Matches in SemOpenAlex for { <https://semopenalex.org/work/W3194549223> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W3194549223 endingPage "55" @default.
- W3194549223 startingPage "50" @default.
- W3194549223 abstract "Objective : to investigate the efficacy and safety of low-dose colchicine in patients with gout receiving urate-lowering therapy (ULT). Patients and methods . A single-center prospective study included 113 patients with gout. The main group consisted of 92 patients who were prescribed colchicine 0.5 mg/day combined with ULT (allopurinol or febuxostat), control group – 21 patients with contraindications to colchicine therapy who received only ULT. Patient data were entered into individual registration cards at the first visit, as well as on the 90th and 180th day after the start of drug intake. The presence of arthritis attacks was recorded by doctor or patient using a validated questionnaire. We compared the mean frequency of arthritis attacks in the groups, their duration and maximum pain intensity according to the visual analogue scale (VAS). Laboratory tests included: complete blood count test, general urinary test, uric acid (UA), blood glucose, alanine aminotransferase, aspartate aminotransferase, creatinine, serum creatine phosphokinase. Results and discussion . Patients who did not receive prophylactic anti-inflammatory therapy had significantly longer duration of the disease and higher number of affected joints. For 6 months of follow-up, there were no arthritis attacks in 54% of patients who were prescribed colchicine, and only in 19% of patients who did not use prophylactic anti-inflammatory therapy (p=0.004). The duration of arthritis attacks and the intensity of pain according to the VAS were also statistically significantly lower in the colchicine group (p<0.031 and p<0.01, respectively). Due to the development of adverse events, related to colchicine therapy, only 3 were excluded from the study. The mean serum UA level by the end of the study in colchicine group did not differ from that in the control group. Conclusion . Administration of colchicine, 0.5 mg/dai for 6 months after initiation of ULT is safe and can reduce the frequency and severity of arthritis attacks." @default.
- W3194549223 created "2021-08-30" @default.
- W3194549223 creator A5008877299 @default.
- W3194549223 creator A5075472187 @default.
- W3194549223 creator A5081260631 @default.
- W3194549223 date "2021-08-15" @default.
- W3194549223 modified "2023-09-25" @default.
- W3194549223 title "Colchicine for acute arthritis attacks prevention in patients with gout during urate-lowering therapy (results of a pilot study)" @default.
- W3194549223 cites W1534146221 @default.
- W3194549223 cites W1964211223 @default.
- W3194549223 cites W1980329869 @default.
- W3194549223 cites W2014787661 @default.
- W3194549223 cites W2123510823 @default.
- W3194549223 cites W2151809600 @default.
- W3194549223 cites W2156131531 @default.
- W3194549223 cites W2297110371 @default.
- W3194549223 cites W2335302945 @default.
- W3194549223 cites W2613563541 @default.
- W3194549223 cites W2736860211 @default.
- W3194549223 cites W2768352561 @default.
- W3194549223 cites W2782554074 @default.
- W3194549223 cites W2785185749 @default.
- W3194549223 cites W2912121841 @default.
- W3194549223 cites W3049648837 @default.
- W3194549223 cites W3160321925 @default.
- W3194549223 cites W4229537562 @default.
- W3194549223 cites W787482168 @default.
- W3194549223 doi "https://doi.org/10.14412/1996-7012-2021-4-50-55" @default.
- W3194549223 hasPublicationYear "2021" @default.
- W3194549223 type Work @default.
- W3194549223 sameAs 3194549223 @default.
- W3194549223 citedByCount "2" @default.
- W3194549223 countsByYear W31945492232022 @default.
- W3194549223 countsByYear W31945492232023 @default.
- W3194549223 crossrefType "journal-article" @default.
- W3194549223 hasAuthorship W3194549223A5008877299 @default.
- W3194549223 hasAuthorship W3194549223A5075472187 @default.
- W3194549223 hasAuthorship W3194549223A5081260631 @default.
- W3194549223 hasBestOaLocation W31945492231 @default.
- W3194549223 hasConcept C126322002 @default.
- W3194549223 hasConcept C141071460 @default.
- W3194549223 hasConcept C14184104 @default.
- W3194549223 hasConcept C197934379 @default.
- W3194549223 hasConcept C2776636253 @default.
- W3194549223 hasConcept C2777077863 @default.
- W3194549223 hasConcept C2779721657 @default.
- W3194549223 hasConcept C2779881121 @default.
- W3194549223 hasConcept C2780261098 @default.
- W3194549223 hasConcept C2780306776 @default.
- W3194549223 hasConcept C2780402116 @default.
- W3194549223 hasConcept C2780932893 @default.
- W3194549223 hasConcept C36880943 @default.
- W3194549223 hasConcept C71924100 @default.
- W3194549223 hasConcept C90924648 @default.
- W3194549223 hasConceptScore W3194549223C126322002 @default.
- W3194549223 hasConceptScore W3194549223C141071460 @default.
- W3194549223 hasConceptScore W3194549223C14184104 @default.
- W3194549223 hasConceptScore W3194549223C197934379 @default.
- W3194549223 hasConceptScore W3194549223C2776636253 @default.
- W3194549223 hasConceptScore W3194549223C2777077863 @default.
- W3194549223 hasConceptScore W3194549223C2779721657 @default.
- W3194549223 hasConceptScore W3194549223C2779881121 @default.
- W3194549223 hasConceptScore W3194549223C2780261098 @default.
- W3194549223 hasConceptScore W3194549223C2780306776 @default.
- W3194549223 hasConceptScore W3194549223C2780402116 @default.
- W3194549223 hasConceptScore W3194549223C2780932893 @default.
- W3194549223 hasConceptScore W3194549223C36880943 @default.
- W3194549223 hasConceptScore W3194549223C71924100 @default.
- W3194549223 hasConceptScore W3194549223C90924648 @default.
- W3194549223 hasIssue "4" @default.
- W3194549223 hasLocation W31945492231 @default.
- W3194549223 hasLocation W31945492232 @default.
- W3194549223 hasOpenAccess W3194549223 @default.
- W3194549223 hasPrimaryLocation W31945492231 @default.
- W3194549223 hasRelatedWork W1530108289 @default.
- W3194549223 hasRelatedWork W1581445871 @default.
- W3194549223 hasRelatedWork W1864638351 @default.
- W3194549223 hasRelatedWork W2127783110 @default.
- W3194549223 hasRelatedWork W2185490382 @default.
- W3194549223 hasRelatedWork W2538925267 @default.
- W3194549223 hasRelatedWork W2735705864 @default.
- W3194549223 hasRelatedWork W3041980498 @default.
- W3194549223 hasRelatedWork W3216437707 @default.
- W3194549223 hasRelatedWork W43853974 @default.
- W3194549223 hasVolume "15" @default.
- W3194549223 isParatext "false" @default.
- W3194549223 isRetracted "false" @default.
- W3194549223 magId "3194549223" @default.
- W3194549223 workType "article" @default.